P2RY12 and atrial fibrillation: However, at that time only clopidogrel and vitamin K antagonists (VKAs) were available, while nowadays for ACS patients stronger P2Y12 inhibitors (prasugrel, ticagrelor) [10, 11] and for AF patients non-vitamin K oral anticoagulants (NOACs) are accessible [12–15].